• Expériences professionnelles
    2011 - Courant
    Completing my studies for Masters in Business Administration. Expected completion August 2011.
    2010 - 2011
    Responsible for the development, presentation and implementation of capital projects within a GMP compliant and Research and Development setting.
    2009 - 2010
    Directed the activities of the Facilities and Engineering department covering both GMP compliant and Research and Development activities. Participated in and responded to local and Group GMP compliance audits. Advanced compliance status of ongoing facility operations. Prepared and provided major capital expenditure proposals in support of facilities development.
    2008 - 2009
    Responsible for GMP plant operations including facilities, manufacturing and materials supply. Led the recruitment and establishment of a core GMP manufacturing team. Enabled the transfer and implementation of a GMP manufacturing process for product to be used in PIII clincal development.
    2003 - 2008
    Secured the GMP production and supply of a recombinant therapeutic protein in support of PII clinical development. Key team member in the design, construction, qualification and start up of biotechnology facility for the manufacture of Active Pharmaceutical Ingredient
    1998 - 2003
    Responsible for securing the supply of GMP grade monoclonal antibody from a Contract Manufacturing Organisation. Program manager for a development of blood product for treatment of haemophilia. Secured progam milestone of IND submission readiness.
    1993 - 1998
    Managed the Monoclonal Antibody Production department responsible for the in house manufacture of monoclonal antibodies used in ClearBlue and ClearPlan rapid diagnostics tests. Led the design, development and operation of an expanded Monoclonal Antibody Unit in support of new product growth. Secured the in licensing and technology transfer of a monoclonal antibody production process utilising bioreactor technology for employment in the expanded production unit.
    1988 - 1993
    Responsible for the establishment of in house mammalian cell culture capability for production of monoclonal antibodies. Supported the pharmaceutical group in the establishment and characterisation of Master and Working Cell Banks used for in the GMP manufacture of monoclonal antibodies.
    1983 - 1988
    Working within the Medical Products Group and responsible for the development of new monoclonal antibody producing cell lines in support of the development of the company's rapid diagnostic assays. Succesfully developed monoclonal antibodies used as components in ClearBlue (Easy) and ClearPlan (Easy) rapid diagnostic tests.
    Voir toutes les Expériences professionnelles (6)
  • Relations
    Chargement... Veuillez patienter...
  • Résultats de recherche Web

    Pages web liées à Robert Lucas

    Voir tous les résultats de recherche Web (50)
Cherchez-vous un(e) autre Robert Lucas ?